Dr. Jean-Marc Sabatier is a Director of research at the French CNRS, with PhD and Habilitation A Diriger Des Recherches (HDR) degrees in Biochemistry and Microbiology and Chief Scientific Officer of Tournoux Biotech, France. He headed several academic research teams like CNRS, INSERM and University, as well as a combined academic-industry research laboratory devoted to the engineering of therapeutic peptides (ERT62, Marseilles, France). He was also a Director of Research for several French private companies as well as a Canadian public company. He acts as a Consultant for top pharmaceutical and cosmetic companies.
Dr. Jean-Marc Sabatier contributed to several books in toxinology and virology, and more than 160 scientific articles, 180 communications, and 53 patents in both biology and chemistry. He is a member of 35 Editorial Boards and Editor-in-Chief of scientific journals. He won the ‘Citizen of the Year Award’ from the Nouvel Economiste (1994) for his work on antivirals. He is a member of a dozen scientific societies, such as the ‘American Peptide Society’ (charter member), ‘European Peptide Society’, ‘American Society for Microbiology’, ‘Biochemical Society’ and ‘New-York Academy of Sciences’.
Dr. Jean-Marc Sabatier’s interest includes Drug design and synthesis (peptides and related compounds), Optimization of peptide structure/conformation (to improve bioactivity, selectivity, solubility, and/or stability), Peptide and protein engineering, Development of peptide-based drugs, Evaluation of research projects.
